Skip to main content
Research
  1. Queen Mary University of London
  2. Research
  3. Publications

Publications: Mr Kunal Shah

Back to Search
Davidson K, Grevitt P, Contreras-Gerenas MF, Bridge KS, Hermida M, Shah KM, Mardakheh FK, Stubbs M et al. ( 2021 ) . Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes . Cell Death and Disease vol. 12 , ( 11 )
Hewitson JP, Shah KM, Brown N, Grevitt P, Hain S, Newling K, Sharp TV, Kaye PM et al. ( 2019 ) . miR-132 suppresses transcription of ribosomal proteins to promote protective Th1 immunity . EMBO Reports vol. 20 , ( 4 )
Foxler DE, Bridge KS, Foster JG, Grevitt P, Curry S, Shah KM, Davidson KM, Nagano A et al. ( 2018 ) . A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia . EMBO Mol Med
Yee D, Shah KM, Coles MC, Sharp TV, Lagos D ( 2017 ) . MicroRNA-155 induction via TNF-α and IFN-γ suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells . J Biol Chem vol. 292 , ( 50 ) 20683 - 20693 .
Bridge KS, Shah KM, Li Y, Foxler DE, Wong SCK, Miller DC, Davidson KM, Foster JG et al. ( 2017 ) . Argonaute Utilization for miRNA Silencing Is Determined by Phosphorylation-Dependent Recruitment of LIM-Domain-Containing Proteins . Cell Reports vol. 20 , ( 1 ) 173 - 187 .
Feber A, Worth DC, Chakravarthy A, de Winter P, Shah K, Arya M, Saqib M, Nigam R et al. ( 2016 ) . CSN1 Somatic Mutations in Penile Squamous Cell Carcinoma . Cancer Research vol. 76 , ( 16 ) 4720 - 4727 .
Leonov G, Shah K, Yee D, Timmis J, Sharp TV, Lagos D ( 2015 ) . Suppression of AGO2 by miR-132 as a determinant of miRNA-mediated silencing in human primary endothelial cells . International Journal of Biochemistry and Cell Biology vol. 69 , 75 - 84 .
Back to Search